Ichiki Takaharu, Uramoto Hidetaka, Shinohara Yoshitake, Kitagawa Naoko, Hara Yoshihiro, Kinoshita Takayuki, Ushio Toshihiko, Eto Seiji, Tsukada Junichi, Takahashi Kojiro
Department of Pharmacy, University Hospital, University of Occupational and Environmental Health, Yahatanishi-hu, Kitahyushu 807-8555, Japan.
J UOEH. 2008 Mar 1;30(1):47-54. doi: 10.7888/juoeh.30.47.
Cancer chemotherapy regimens which had been used at a ward and outpatient chemotherapy in various departments were collected and made available to everybody in October, 2003. However, it was difficult to manage cancer chemotherapy regimens in real time, from the viewpoint of risk management. Then, the Cancer Chemotherapy Center took the leading part and established a chemotherapy exploratory committee, which consists of 4 doctors, 2 nurses and 2 pharmacists, in June, 2006. The department of pharmacy could control all cancer chemotherapy regimens by this system, and lead the proper use of increasing anticancer agents. Inquiries on prescription by the pharmacist contributed to proper medical treatment. The role of the cancer chemotherapy exploratory committee and its outcome are described for the purpose of the prevention of medical accidents in this paper.
收集了各科室在病房和门诊化疗中使用过的癌症化疗方案，并于2003年10月向所有人公开。然而，从风险管理的角度来看，实时管理癌症化疗方案存在困难。于是，癌症化疗中心于2006年6月牵头成立了一个化疗探索委员会，该委员会由4名医生、2名护士和2名药剂师组成。通过该系统，药剂科能够控制所有癌症化疗方案，并引导正确使用日益增多的抗癌药物。药剂师对处方的询问有助于合理治疗。本文旨在描述癌症化疗探索委员会的作用及其成果，以预防医疗事故。
